Switch to
More onapp

How to use scorecard? Learn more

Samrat Pharmachem Ltd

SAMRATPH
MaterialsCommodity Chemicals
SmallcapWith a market cap of ₹124 cr, stock is ranked 2,881
High RiskStock is 3.62x as volatile as Nifty
405.003.25 (-0.80%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

MaterialsCommodity Chemicals
SmallcapWith a market cap of ₹124 cr, stock is ranked 2,881
High RiskStock is 3.62x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
19.41
PB RatioPB Ratio
1.92
Dividend YieldDiv. Yield
0.25%
Sector PESector PE
31.00
Sector PBSector PB
3.52
Sector Div YldSctr Div Yld
1.32%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Samrat Pharmachem Limited is engaged in the production of pharmaceutical chemicals like Iodine salts and Bromine salts. The Company's finished products are used in various industries, including pharmaceuticals, chemicals, food, fertilizer and salt.

Financial TrendFinancial statements 

2021202220232024179.48222.38311.13282.965.3317.1916.652.15
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnNov 21, 2024

SAMRAT PHARMACHEM LTD.-$ - 530125 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

SAMRAT PHARMACHEM LTD.-$ - 530125 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

Result 
Announced OnNov 14, 2024

SAMRAT PHARMACHEM LTD.-$ - 530125 - Un-Audited Financial Results For The Quarter Ended September 30, 2024 | Download

SAMRAT PHARMACHEM LTD.-$ - 530125 - Un-Audited Financial Results For The Quarter Ended September 30, 2024 | Download

Cash Dividend 
Ex. DateSep 19, 2024

Final • Div/Share: ₹ 1

See all events